Post by
jfm1330 on Mar 09, 2021 11:55am
Cytodyn down
Lost 50% in the last few days on marginal efficacy results with covid trial. Another proof the hard facts on humans always catch up with the pump, negatively or positively, it depends on the facts reported.
Comment by
ANALIAS00 on Mar 09, 2021 12:04pm
It is very frustrating to see a cie that we believe is undervalued but at the end, fundamentals will fix it. Lets hope TH's results will be positive. This will fix SP the same way it did for Cytodyn but with a curve on the opposite side this time :o)
Comment by
jfm1330 on Mar 09, 2021 2:08pm
28% reduction in mortality on only 62 patients that were critically ill. How many of these 62 patients were on placebo? To me it looks like unclear results on such a small sample.
Comment by
SPCEO1 on Mar 09, 2021 3:16pm
It is one of the nuttiest things I have ever seen. And I have seen a lot of nutty things over my 45 years of investing. It has been obvious forever that CYDY likely had nothing medically and were a financial basket case . Yet they were able to get a huge valuation from retail investors. TH has done so much better than CYDY but you would never know that from the stock performance.
Comment by
muslix1 on Mar 09, 2021 4:06pm
JFM you dream...80% or more vaccinated in America impossible... QANON think the are injected the 5G in the arm... all Trumpiste and red neck... Wow. a low 60 maybe
Comment by
jfm1330 on Mar 09, 2021 4:42pm
The biden administration will not make vaccination mandatory, but they can required vaccination proof to be able to have access to stuff, like flying. So only the real conspiracy people will refuse it. The same apply here in Canada. You want to be silly? OK, but you will be restricted in some avtivities.
Comment by
muslix1 on Mar 09, 2021 5:21pm
I think we have to trust Dr Fauci in USA end Dr Tam in Canada ... get vaccinated it's simple ... this not a republican or democrate story it's science i am waiting for my turn in few weeks
Comment by
Spartrap on Mar 09, 2021 3:12pm
FWIW, I like RIGL's chances. Solid rationale established by independent research pointing at major role of the SYK pathway in covid-19-associated ARDS. Fostamatinib already on the market, could see EUA. Rigel runs its own P3, NIH runs a P2 with topline results expected in April.
Comment by
qwerty22 on Mar 09, 2021 2:31pm
I haven't looked at the cydy data but here's an analysis that uses the right tool set to parse this type of data, it doesn't read good. https://seekingalpha.com/article/4412192-cytodyn-parsing-failure